author-photo

Christopher R. Garrett

University of Texas MD Anderson Cancer Center
University of South Florida

112

Papers

6533

Citations

Citation Trend

Filter By

Papers (85) Sort By

Journal Conference Others

Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer

2018 Journal of Global Oncology
Show All
- Source
- Cite
- Save
Citations (7)
Heterogeneity of acquired KRAS and EGFR mutations in colorectal cancer patients treated with anti-EGFR monoclonal antibodies.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (7)
Antitumor activity in ras-driven tumors by blocking akt and mek

2015 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (99)
Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment

2015 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (159)
Clinical utility of a circulating cell-free DNA assay for clinical trial enrollment in refractory metastatic colorectal cancer patients.

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Association between KRAS mutation and lung metastasis in advanced colorectal cancer.

2015 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (55)
Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response

2015 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (28)
The metformin effect on survival in Middle Eastern patients (pts) with type II diabetes (DM) and colorectal cancer (CRC).

2015 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Frequency of concurrent gene mutations and copy number alterations in circulating cell-free DNA (cfDNA) from refractory metastatic CRC patients.

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Association of CpG island methylator phenotype (CIMP) with inferior progression-free survival with anti-EGFR monoclonal antibody therapy in metastatic colorectal cancer.

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)